Vanda Pharmaceuticals Company Profile (NASDAQ:VNDA)

About Vanda Pharmaceuticals

Vanda Pharmaceuticals logoVanda Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of pharmaceutical products for the treatment of central nervous system (CNS) disorders. The Company's product portfolio includes HETLIOZ (tasimelteon), Fanapt (iloperidone), Tradipitant (VLY-686), Trichostatin A and AQW051. The Company offers HETLIOZ (tasimelteon) for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24). The Company offers Fanapt (iloperidone) for the treatment of schizophrenia. Additionally, its distribution partners launched Fanapt in Israel and Mexico. Tradipitant (VLY-686) is a small molecule neurokinin-1 receptor (NK-1R) antagonist, which is in clinical development for the treatment of chronic pruritus in atopic dermatitis. Trichostatin A is a small molecule histone deacetylase (HDAC) inhibitor. AQW051 is a Phase II alpha-7 nicotinic acetylcholine receptor partial agonist. It is indicated for the treatment of CNS Disorders.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: VNDA
  • CUSIP: 92165910
Key Metrics:
  • Previous Close: $16.26
  • 50 Day Moving Average: $14.98
  • 200 Day Moving Average: $11.24
  • 52-Week Range: $6.91 - $18.00
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 104.00
  • P/E Growth: -1.70
  • Market Cap: $720.25M
  • Outstanding Shares: 43,284,000
  • Beta: 1.53
Profitability:
  • Net Margins: -31.85%
  • Return on Equity: -22.51%
  • Return on Assets: -13.99%
Debt:
  • Current Ratio: 3.10%
  • Quick Ratio: 3.08%
Additional Links:
Companies Related to Vanda Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Vanda Pharmaceuticals (NASDAQ:VNDA) (?)
Ratings Breakdown: 5 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $19.00 (14.18% upside)

Analysts' Ratings History for Vanda Pharmaceuticals (NASDAQ:VNDA)
Show:
DateFirmActionRatingPrice TargetDetails
8/29/2016Brean CapitalReiterated RatingBuy$20.00 -> $24.00View Rating Details
8/26/2016JMP SecuritiesBoost Price TargetMarket Outperform$18.00 -> $22.00View Rating Details
8/18/2016Piper Jaffray Cos.Set Price TargetBuy$16.00View Rating Details
6/10/2016Jefferies GroupReiterated RatingBuyView Rating Details
3/14/2016Canaccord GenuityReiterated RatingBuy$18.00View Rating Details
(Data available from 10/1/2014 forward)

Earnings

Earnings History for Vanda Pharmaceuticals (NASDAQ:VNDA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/1/2016        
7/27/2016Q216($0.23)($0.11)$36.03 million$36.02 millionViewListenView Earnings Details
5/4/2016Q116($0.24)($0.17)$32.48 million$33.30 millionViewListenView Earnings Details
2/10/2016Q415($0.26)($0.23)$31.34 million$31.85 millionViewListenView Earnings Details
11/3/2015Q315($0.20)($0.11)$28.58 million$28.34 millionViewListenView Earnings Details
7/29/2015Q2($0.32)($0.01)$24.55 million$27.60 millionViewListenView Earnings Details
5/6/2015Q1($0.25)($0.24)$20.18 million$22.20 millionViewListenView Earnings Details
2/19/2015Q4$0.56($0.36)$35.57 million$15.40 millionViewListenView Earnings Details
10/27/2014Q314($0.39)($0.04)$12.20 million$14.80 millionViewListenView Earnings Details
8/7/2014Q2($0.70)($0.64)$10.00 million$10.80 millionViewListenView Earnings Details
5/8/2014Q1($0.29)($0.79)$8.50 million$9.10 millionViewListenView Earnings Details
2/13/2014Q413($0.20)($0.23)$8.50 million$8.80 millionViewListenView Earnings Details
11/7/2013Q313($0.30)($0.43)$8.45 million$8.70 millionViewListenView Earnings Details
7/31/2013Q2 2013($0.22)($0.26)$8.43 million$8.30 millionViewListenView Earnings Details
5/9/2013Q1 2013($0.25)($0.15)$8.42 million$8.10 millionViewListenView Earnings Details
2/12/2013Q4 2012($0.22)($0.23)$8.60 million$7.90 millionViewListenView Earnings Details
11/7/2012Q312($0.22)($0.19)$8.40 million$8.28 millionViewN/AView Earnings Details
8/2/2012($0.27)($0.28)ViewN/AView Earnings Details
5/8/2012($0.16)($0.28)ViewN/AView Earnings Details
2/14/2012($0.19)($0.20)ViewN/AView Earnings Details
11/4/2011($0.12)($0.11)ViewN/AView Earnings Details
8/4/2011($0.07)($0.05)ViewN/AView Earnings Details
2/10/2011($0.02)$0.08ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Vanda Pharmaceuticals (NASDAQ:VNDA)
Current Year EPS Consensus Estimate: $-0.68 EPS
Next Year EPS Consensus Estimate: $0.16 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20161($0.19)($0.19)($0.19)
Q4 20161($0.24)($0.24)($0.24)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Vanda Pharmaceuticals (NASDAQ:VNDA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Vanda Pharmaceuticals (NASDAQ:VNDA)
Insider Ownership Percentage: 8.45%
Institutional Ownership Percentage: 86.06%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/23/2016James E FlynnInsiderSell1,120,461$16.56$18,554,834.16View SEC Filing  
9/19/2016James E FlynnInsiderSell547,886$15.66$8,579,894.76View SEC Filing  
1/4/2016James Patrick KellyCFOSell9,564$8.96$85,693.44View SEC Filing  
1/4/2016Mihael Hristos PolymeropoulosCEOSell21,353$8.96$191,322.88View SEC Filing  
1/4/2016Paolo BaroldiSVPSell12,380$8.96$110,924.80View SEC Filing  
12/11/2015James E FlynnInsiderBuy1,201,364$8.38$10,067,430.32View SEC Filing  
9/10/2015Mihael Hristos PolymeropoulosCEOSell131,739$12.68$1,670,450.52View SEC Filing  
5/22/2015Mihael Hristos PolymeropoulosCEOSell186,395$10.36$1,931,052.20View SEC Filing  
3/9/2015Richard W DuganDirectorSell4,804$10.69$51,354.76View SEC Filing  
12/23/2014James E FlynnInsiderBuy162,014$14.40$2,333,001.60View SEC Filing  
3/14/2014Thomas WatkinsDirectorSell35,000$17.66$618,100.00View SEC Filing  
11/21/2013Robert RepellaSVPSell107,500$12.03$1,293,225.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Vanda Pharmaceuticals (NASDAQ:VNDA)
DateHeadline
News IconStock in Limelight: Vanda Pharmaceuticals Inc. (NASDAQ:VNDA), Smith & Nephew SNATS, Inc. (NYSE:SNN) - Newburgh Press (NASDAQ:VNDA)
newburghpress.com - October 1 at 8:45 AM
News IconVNDA Parity Calls and Combos Trade (NASDAQ:VNDA)
www.theoptionsinsider.com - September 30 at 7:13 PM
News IconTime To Put On The Watch List? – Intrexon (NYSE:XON), Vanda ... - The Voice Registrar (NASDAQ:VNDA)
voiceregistrar.com - September 30 at 7:28 AM
News IconNotable Thursday Option Activity: VNDA, AIRM, LL (NASDAQ:VNDA)
www.stockoptionschannel.com - September 29 at 7:53 PM
mysmartrend.com logoUptrend Call Working As Vanda Pharmaceuticals Stock Rises 59.8% (VNDA) (NASDAQ:VNDA)
www.mysmartrend.com - September 28 at 7:46 PM
News IconBiotech Stocks To Put On Your Watch List: Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA), Exelixis, Inc. (NASDAQ:EXEL) - The Voice Registrar (NASDAQ:VNDA)
voiceregistrar.com - September 27 at 7:55 PM
News IconBiotech Stocks To Put On Your Watch List: PTC Therapeutics, Inc. (NASDAQ:PTCT), Vanda Pharmaceuticals, Inc ... - The Voice Registrar (NASDAQ:VNDA)
voiceregistrar.com - September 27 at 9:56 AM
investing.com logoU.S. stocks lower though Twitter soars 20% (NASDAQ:VNDA)
www.investing.com - September 23 at 7:21 PM
reuters.com logoExclusive - Vanda Pharmaceuticals prepares to explore a sale: sources - Reuters UK (NASDAQ:VNDA)
uk.reuters.com - September 23 at 7:01 AM
News IconHC Stocks Momentum! Northwest Biotherapeutics, Inc (NWBO), Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) - share market updates (press release) (NASDAQ:VNDA)
sharemarketupdates.com - September 23 at 7:01 AM
bizjournals.com logoMeet the Fastest Growing Companies 2016 finalists (NASDAQ:VNDA)
www.bizjournals.com - September 23 at 7:01 AM
reuters.com logoExclusive: Vanda Pharmaceuticals prepares to explore a sale - sources - Reuters (NASDAQ:VNDA)
www.reuters.com - September 22 at 7:38 PM
News IconTrading the Biotech News: Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA), Vitae Pharmaceuticals, Inc. (NASDAQ:VTAE) - The Voice Registrar (NASDAQ:VNDA)
voiceregistrar.com - September 21 at 11:52 AM
News IconWhat are Research Firms Saying About Vanda Pharmaceuticals Inc ... - Frisco Fastball (NASDAQ:VNDA)
friscofastball.com - September 20 at 6:48 AM
News IconVanda Pharmaceuticals Inc. (NASDAQ:VNDA) reported actual EPS of -0.11 in the last Quarter - Newburgh Press (NASDAQ:VNDA)
newburghpress.com - September 17 at 7:10 AM
News IconBiotech Companies To Look Out For: Vanda Pharmaceuticals, Inc. (VNDA), Merrimack Pharmaceuticals, Inc. (MACK) - The Independent Republic (NASDAQ:VNDA)
theindependentrepublic.com - September 17 at 7:10 AM
News IconNews review of 2 biotech stocks: Cempra, Inc. (NASDAQ:CEMP), Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA) - The Voice Registrar (NASDAQ:VNDA)
voiceregistrar.com - September 15 at 11:45 AM
mysmartrend.com logoShares of VNDA Up 55.3% Since Uptrend Call on Shares (NASDAQ:VNDA)
www.mysmartrend.com - September 14 at 12:22 PM
News IconNext Weeks Broker Price Targets For Vanda Pharmaceuticals Inc. (VNDA) (NASDAQ:VNDA)
magseriesusa.net - September 14 at 12:22 PM
News IconNext Weeks Broker Price Targets For Vanda Pharmaceuticals Inc ... - National Daily Press (NASDAQ:VNDA)
www.nationaldailypress.com - September 12 at 7:28 AM
News IconStock Tracker: Earnings & Estimates for Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) - Frisco Fastball (NASDAQ:VNDA)
friscofastball.com - September 10 at 7:28 AM
News IconThe Sell-side Consensus is in on Vanda Pharmaceuticals Inc. (NASDAQ:VNDA); Earnings & Target Updates - National Daily Press (NASDAQ:VNDA)
www.nationaldailypress.com - September 9 at 7:35 PM
News IconActive Biotech Stock News: Vanda Pharmaceuticals, Inc. (VNDA), Peregrine Pharmaceuticals, Inc. (PPHM) - The Independent Republic (NASDAQ:VNDA)
theindependentrepublic.com - September 8 at 11:54 AM
News IconVanda Pharmaceuticals Inc. (NASDAQ: VNDA) shares touch new 52-week high - BNB Daily (blog) (NASDAQ:VNDA)
www.baseball-news-blog.com - September 8 at 11:54 AM
News IconBiotech news that matter for investors: Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA), NewLink Genetics Corporation ... - The Voice Registrar (NASDAQ:VNDA)
voiceregistrar.com - September 6 at 8:04 PM
realistinvestor.com logoAccounts Payable For Vanda Pharmaceuticals Inc. (NASDAQ:VNDA ... - RealistInvestor.com (NASDAQ:VNDA)
www.realistinvestor.com - September 4 at 7:04 PM
streetinsider.com logoVanda Pharmaceuticals (VNDA) Announces USPTO Dismissal of ... - StreetInsider.com (NASDAQ:VNDA)
www.streetinsider.com - August 31 at 7:39 AM
4-traders.com logoVanda Pharmaceuticals : USPTO Dismisses Petition for Inter Partes Review of Fanapt® Patent (NASDAQ:VNDA)
www.4-traders.com - August 30 at 7:52 PM
streetinsider.com logoVanda Pharmaceuticals (VNDA) Announces USPTO Dismissal of '432 Patent Inter Partes Review (NASDAQ:VNDA)
www.streetinsider.com - August 30 at 7:52 PM
publicnow.com logoUSPTO Dismisses Petition for Inter Partes Review of Fanapt® Patent (NASDAQ:VNDA)
www.publicnow.com - August 30 at 7:52 PM
News IconVanda Pharmaceuticals Inc. (NASDAQ:VNDA): It’s All About Timing The Breakout For Quick Profit (NASDAQ:VNDA)
www.marketnewscall.com - August 29 at 8:04 PM
streetinsider.com logoVanda Pharmaceuticals (VNDA) Affirms Receipt of Favorable Court Decision in Fanapt Patent Suit (NASDAQ:VNDA)
www.streetinsider.com - August 27 at 7:10 PM
marketexclusive.com logoWhere Things Stand For Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) In Fanapt Patent Suit (NASDAQ:VNDA)
marketexclusive.com - August 27 at 7:10 PM
istreetwire.com logo3 Trending Stocks: Vanda Pharmaceuticals, Inc. (VNDA), The Gap, Inc. (GPS), Coeur Mining, Inc. (CDE) - iStreetWire (NASDAQ:VNDA)
istreetwire.com - August 26 at 7:43 PM
bizjournals.com logoVanda Pharmaceuticals fends off patent challenge from generic competitor (NASDAQ:VNDA)
www.bizjournals.com - August 26 at 7:43 PM
thestreet.com logoVanda Pharma (VNDA) Stock Price Target Upped on Drug Patent Ruling (NASDAQ:VNDA)
www.thestreet.com - August 26 at 7:43 PM
News IconNotable Trending Stocks: Vanda Pharmaceuticals Inc.(NASDAQ:VNDA), Dollar Tree, Inc. (NASDAQ:DLTR) - NYSE Journal (press release) (NASDAQ:VNDA)
stockznews.com - August 26 at 11:00 AM
News IconEyes Catching Healthcare Stocks- Nymox Pharmaceutical (NASDAQ:NYMX), Vanda Pharmaceuticals (NASDAQ:VNDA) - Seneca Globe (NASDAQ:VNDA)
www.senecaglobe.com - August 26 at 11:00 AM
finance.yahoo.com logoVanda Pharmaceuticals (VNDA) Catches Eye: Stocks Up 20% (NASDAQ:VNDA)
finance.yahoo.com - August 26 at 11:00 AM
finance.yahoo.com logoVanda Stock Up on Favorable U.S. Court Ruling for Fanapt (NASDAQ:VNDA)
finance.yahoo.com - August 26 at 11:00 AM
capitalcube.com logoETF’s with exposure to Vanda Pharmaceuticals, Inc. : August 26, 2016 (NASDAQ:VNDA)
www.capitalcube.com - August 26 at 11:00 AM
News IconVanda Patents Found Valid and Infringed in Fanapt® ANDA Litigation (NASDAQ:VNDA)
ih.advfn.com - August 25 at 8:25 PM
News IconVanda Pharmaceuticals Inc. (NASDAQ:VNDA): That’s How Our Subscribers bought at $11.90, Made 25% Quickly (NASDAQ:VNDA)
www.marketnewscall.com - August 25 at 8:25 PM
schaeffersresearch.com logoOptions Bulls Pounce as Vanda Pharmaceuticals Inc. (VNDA) Gaps Higher (NASDAQ:VNDA)
www.schaeffersresearch.com - August 25 at 8:24 PM
fool.com logoWhy Tiffany, AEP Industries, and Vanda Pharmaceuticals Jumped Today (NASDAQ:VNDA)
www.fool.com - August 25 at 7:22 PM
realistinvestor.com logoVanda Pharmaceuticals Inc. (NASDAQ:VNDA) Reports Accounts Payable Of $17.933 - RealistInvestor.com (NASDAQ:VNDA)
www.realistinvestor.com - August 21 at 7:13 AM
capitalcube.com logoETF’s with exposure to Vanda Pharmaceuticals, Inc. : August 11, 2016 (NASDAQ:VNDA)
www.capitalcube.com - August 11 at 8:48 PM
4-traders.com logoGenocea Biosciences : Research Report Initiation on Biotech Stocks -- Agenus, ProNAi Therapeutics, Vanda Pharma, and Genocea Biosciences (NASDAQ:VNDA)
www.4-traders.com - August 11 at 11:37 AM
mysmartrend.com logoUptrend Call Working As Vanda Pharmaceuticals Stock Rises 19.6% (VNDA) (NASDAQ:VNDA)
www.mysmartrend.com - August 11 at 11:37 AM
nasdaq.com logoNoteworthy Wednesday Option Activity: VNDA, IP, PVH (NASDAQ:VNDA)
www.nasdaq.com - August 10 at 8:50 PM

Social

Vanda Pharmaceuticals (NASDAQ:VNDA) Chart for Saturday, October, 1, 2016


Last Updated on 10/1/2016 by MarketBeat.com Staff